PDS Biotechnology Corporation Common Stock

Go to PDS Biotechnology Corporation Common Stock Website

$3.82

(%)
Live
Previous Close

$3.82

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$140.1 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, pros...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Virtual Webinar Updated VERSATILE-002 Phase 2 Trial Results, Unmet Treatment Needs in Advanced Head and Neck Cancer and Planned Triple Combination Trial to be held May 8, 2024 Virtual Webinar Updated VERSATILE-002 Phase 2 Trial Results, Unmet Treatment Needs in Advanced Head and Neck Cancer and Planned Triple Combination Trial to be held May 8, 2024

Related tickers: PDSB.

Read Full Article

Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Related tickers: PDSB.

Read Full Article
Trending Tickers
LASE

XNAS

$2.04
(%)
PACW

XNAS

$7.54
(%)
SMFL

XNAS

$3.58
(%)
SQ

XNYS

$69.47
(%)
MLGO

XNAS

$0.00
(%)